EQS-News: Symrise Reports Third Quarter 2025 Sales

Press Release

Trading Statement Q3 2025

—

Holzminden, 28 October 2025                

Symrise AG, a leading global supplier of fragrances and flavors, cosmetic ingredients as well as functional ingredients, continued to execute its ONE Symrise Strategy to drive profitable growth and advance the ONE SYM Transformation. Symrise delivered organic sales growth despite the continued challenging global environment.

For Q3 2025, Symrise achieved organic sales growth of 1.4%. Considering portfolio and exchange rate effects of €54 million, reported revenue totalled €1,223 million. A healthy pipeline of sales opportunities and dynamic project vitality with selected customers in key markets offset by high year-on-year comparables. On a nine-month basis, Symrise achieved sales of €3,776 million, or 2.6% organic growth.

Jean-Yves Parisot, CEO of Symrise AG, commented, “Our transformation continues to gain strong momentum, and we are now accelerating our efforts to shape the next chapter of Symrise. We are making clear choices about how to win and create value — focusing on growth opportunities, differentiated innovation, as well as a more efficient supply chain and sales and marketing operating model to better serve our customers.

During the third quarter, we remained focused on controlling what we can control to position Symrise for continued strength. Ongoing macroeconomic and geopolitical challenges led to pronounced market dynamics and near-term variability. Softening consumer demand in several markets and continued tariff impacts on end consumers that are not expected to reverse in the near term. Taking this into consideration, we believe it is prudent to moderate our organic sales guidance to account for the increasing challenging macro to a range of 2.3% to 3.3% from our previous outlook of 3.0% to 5.0%.

As we execute our purpose-driven ONE Symrise Strategy enabled by the multi-year ONE SYM Transformation, we continue to focus on driving durable profitable growth, generating robust business free cash flow, and delivering compounding returns. I thank our 13,000 Symrisers worldwide for their dedication and continued commitment as we advance.”
 

Q3 2025 Segment Sales Performance

Taste, Nutrition & Health Segment

The Taste, Nutrition & Health segment achieved organic sales growth of 1.2%. Taking into account portfolio and exchange rate effects of €37 million, segment revenue was €750 million in reported currency compared to €777 million in Q3 2024. On a nine-month basis the segment achieved sales of €2,314 million, or  2.6% organic growth.

• The Food & Beverage division achieved industry-leading single-digit growth in the third quarter, despite double-digit year-on-year comparables, as Symrise continued to meet customers’ needs through a leading portfolio of innovative, differentiated products and solutions. The highest growth was reported from the Europe, Africa, and Middle East (EAME) region. The Beverages business unit showed strength and delivered double-digit organic growth, maintaining strong momentum. Naturals also recorded single-digit organic sales growth while sales in Savory were slightly increased.
• The Pet Food division continued to be in line with the market and sales at the level of the previous year due to price adjustments made at the beginning of the year in Pet Nutrition.

Scent & Care Segment

The Scent & Care segment achieved organic sales growth of 1.7%, primarily driven by solid performance in Fragrance, partially offset by weaker results in Aroma Molecules. Taking into account portfolio and currency effects, segment revenue was €473 million in reported currency compared to €481 million in Q3 2024. On a nine-month basis the segment achieved sales of €1,462 million, or 2.5% organic growth.

• The Fragrance division achieved mid-single-digit organic growth in the third quarter, supported by continued strength in both the Consumer Fragrance and Fine Fragrance business units. Consumer Fragrance delivered mid-single-digit growth despite challenging double-digit prior-year comparables, supported by a strong business pipeline. Fine Fragrance recorded mid-single-digit growth, supported by new customer wins. Oral Care product solutions achieved moderate growth.
• The Aroma Molecules division was impacted by price and volume pressure due to increased competition from Asia and overall market volatility. Consequently, the growth was below the prior-year period.
• The Cosmetic Ingredients division achieved low single-digit organic growth. The division recorded its first organic growth for this year, signalling signs of recovery from previous destocking effects in UV Filters.

ONE SYM Transformation Update

Symrise is now accelerating its efforts around the ONE SYM Transformation, an organization-wide change program, advancing portfolio optimization, efficiency and performance driven leadership. Symrise identified €40 million in cost savings for 2025, with €30 million realized during the first nine months of the year. Efficiency gains are being partially reinvested into talents, digitalization and innovation to drive profitable growth.

Symrise continued to proactively manage its portfolio, in line with the actions announced at H1 2025. The evaluation of strategic alternatives for Terpene ingredients is progressing according to plan.

During the third quarter, Symrise continued to strengthen the leadership bench with additional key appointments to support the implementation of the ONE Symrise Transformation journey.

Successful Placement of €800 Million Bond

In September Symrise successfully placed its inaugural rated Eurobond with a volume of €800 million, a 7-year maturity, and a 3.25% coupon, following multiple oversubscriptions and strong demand from international investors. Proceeds will primarily be used for the early refinancing of debt maturities.

Symrise also received inaugural investment grade credit ratings from S&P Global and Moody’s during the third quarter. The agencies have assigned long-term issuer ratings of BBB+ (S&P Global) and Baa1 (Moody’s), both with stable outlooks.

Full Year 2025 Outlook

Taking into account a more challenging than expected global demand environment, we are updating our annual guidance as follows:

• Moderating organic growth outlook to 2.3%-3.3% versus prior outlook 3.0%-5.0%
• Reaffirming EBITDA margin outlook of ~21.5% and
• Business Free Cash Flow as a percent of sales of ~14%
• Reaffirming annual cost savings of €40 million

Symrise reaffirms its 2028 mid-term targets, aiming for an organic growth of 5% to 7% (CAGR), an EBITDA margin in the range of 21% to 23%, and Business Free Cash Flow percent of sales of more than 14%.

A copy of this press release, the presentation and financial report can be found on the Investor Relations section of our website at https://www.symrise.com/investors/financial-results/.

About Symrise: Symrise is a global supplier of fragrances and flavors, cosmetic basic and active ingredients as well as functional ingredients. Our customers include perfume, cosmetics, food and beverage manufacturers, the pharmaceutical industry and producers of dietary supplements and pet food. With sales of around €5.0 billion in the 2024 financial year, we are one of the world's leading providers. The Group, headquartered in Holzminden, Germany, has more than 100 branches in Europe, Africa and the Middle East, Asia, the USA and Latin America. Together with our customers, Symrise develops new ideas and marketable concepts for products that have become an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...